Bioanalytix Knowledge Centre

Bioanalytix explores how evidence about your biology may change the assumptions underlying long-term financial planning.

Your DNA does not tell Bioanalytix how long you will live. Genetic evidence can contribute information about biological pathways, disease susceptibility, resilience and traits associated with health and longevity. Bioanalytix brings that evidence together with financial and planning information so you can explore alternative futures rather than predict one.

From biology to financial planning

Traditional financial plans make assumptions about the future: how long retirement may last, how spending may change, how much liquidity may be required and what assets may remain later in life.

Bioanalytix asks a different question:

What if we could explore those assumptions using more information about you?

The Bioanalytix framework connects:

Genetic evidence | health and longevity uncertainty | planning horizon | retirement needs | financial scenarios | estate outcomes

Genetic evidence is one input into that process. It does not replace medical information, lifestyle, family history, financial circumstances or professional judgement.

What you can learn here

Understanding Bioanalytix

Learn how Bioanalytix turns selected genetic observations and other information into governed evidence that can inform planning scenarios.

Genetics and evidence

Explore the science of longevity, health, disease susceptibility, physical performance and resilience — including what individual variants can and cannot tell us.

Financial planning

Understand why longevity uncertainty matters for retirement income, investment horizon, asset allocation, withdrawal strategies, healthcare contingencies and estate planning.

Evidence, limitations and privacy

Learn how Bioanalytix distinguishes stronger evidence from emerging research, why genetic associations are probabilistic rather than deterministic, and how genetic information is handled.

Three levels of evidence

Bioanalytix is designed to distinguish between different strengths of scientific evidence.

Established evidence Evidence that has been repeatedly observed and has comparatively strong scientific support for the purpose in which it is being considered.

Emerging evidence Credible scientific associations that remain dependent on population, context, methodology or further replication.

Exploratory evidence Research that may be scientifically interesting and worth following, but should not by itself drive a health or financial conclusion.

Evidence can move between these categories as research develops.

An evolving evidence base

Human genetics is developing rapidly. Genome-wide association studies have identified thousands of variants associated with complex traits and diseases, while polygenic approaches increasingly combine information from many variants.

These developments create opportunities for more personalised risk assessment, but they also introduce important limitations. Genetic effects may be small, findings may not transfer equally across ancestry groups, environmental factors remain important, and association does not necessarily establish causation.

Bioanalytix therefore treats genetic research as an evolving evidence layer, not a fixed verdict about your future.

Bioanalytix is designed for exploration and financial planning. Genetic information presented by the platform is not a diagnosis, and financial scenarios are not personal medical, legal, tax or investment advice.